Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATOS | TMO | ISRG | IDXX | EW |
| Company | Atossa Therapeutics Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Idexx Laboratories | Edwards Lifesciences Corp |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.9600 | 576.62 | 545.47 | 700.94 | 84.35 |
| High | 0.9900 | 579.08 | 553.39 | 716.45 | 84.60 |
| Low | 0.8944 | 570.84 | 542.71 | 696.88 | 83.64 |
| Latest | 0.9048 | 578.90 | 547.36 | 707.50 | 84.24 |
| Change | +0.0548 | +5.09 | -8.56 | +5.67 | +0.32 |
| % Change | +6.45% | +0.89% | -1.54% | +0.81% | +0.38% |
| Volume | 5,824,300 | 1,226,400 | 1,573,800 | 417,400 | 2,104,100 |
| 20-Day Average Volume | 896,160 | 1,619,490 | 1,647,050 | 606,260 | 3,424,750 |
| Previous Close | 0.8500 | 573.81 | 555.92 | 701.83 | 83.92 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7819 | 579.10 | 562.96 | 715.24 | 85.15 |
| 20-Day Raw Stochastic | 72.08% | 48.93% | 19.57% | 40.34% | 24.20% |
| 20-Day Relative Strength | 58.37 | 56.38 | 51.53 | 53.01 | 53.21 |
| Weighted Alpha | -8.88 | +19.17 | +2.36 | +63.83 | +17.38 |
| Today's Opinion | 56% Buy | 72% Buy | 64% Buy | 88% Buy | 88% Buy |
| Previous Opinion | 16% Buy | 72% Buy | 72% Buy | 88% Buy | 88% Buy |
| Last Month's Opinion | 24% Buy | 100% Buy | 40% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +19.13% since 12/04/25 | +0.64% since 12/04/25 | -3.74% since 12/04/25 | -1.39% since 12/04/25 | -1.80% since 12/04/25 |
| Low | 0.7671 on 12/05/25 | 561.91 on 12/09/25 | 542.71 on 12/11/25 | 693.72 on 12/10/25 | 83.07 on 12/09/25 |
| High | 0.9900 on 12/11/25 | 579.09 on 12/05/25 | 576.88 on 12/05/25 | 722.71 on 12/05/25 | 87.89 on 12/05/25 |
| 1-Month | |||||
| %Chg | +9.31% since 11/11/25 | -1.29% since 11/11/25 | -4.34% since 11/11/25 | -0.70% since 11/11/25 | -1.08% since 11/11/25 |
| Low | 0.6848 on 12/02/25 | 556.46 on 11/18/25 | 538.83 on 11/18/25 | 665.25 on 11/18/25 | 83.07 on 12/09/25 |
| High | 0.9900 on 12/11/25 | 602.32 on 11/25/25 | 582.41 on 11/26/25 | 769.98 on 11/26/25 | 87.89 on 12/05/25 |
| 3-Month | |||||
| %Chg | +9.91% since 09/11/25 | +17.80% since 09/11/25 | +20.07% since 09/11/25 | +9.66% since 09/11/25 | +7.99% since 09/11/25 |
| Low | 0.6848 on 12/02/25 | 456.67 on 09/29/25 | 427.84 on 10/14/25 | 600.57 on 10/01/25 | 72.30 on 10/13/25 |
| High | 1.2900 on 10/09/25 | 602.32 on 11/25/25 | 582.41 on 11/26/25 | 769.98 on 11/26/25 | 87.89 on 12/05/25 |
| 6-Month | |||||
| %Chg | +3.05% since 06/11/25 | +39.44% since 06/11/25 | +4.78% since 06/11/25 | +34.97% since 06/11/25 | +11.62% since 06/11/25 |
| Low | 0.6848 on 12/02/25 | 385.46 on 06/18/25 | 427.84 on 10/14/25 | 506.91 on 07/16/25 | 72.30 on 10/13/25 |
| High | 1.2900 on 10/09/25 | 602.32 on 11/25/25 | 582.41 on 11/26/25 | 769.98 on 11/26/25 | 87.89 on 12/05/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 116,874 | 217,497,376 | 196,215,968 | 56,494,576 | 48,884,472 |
| Shares Outstanding, K | 129,171 | 375,708 | 358,477 | 79,851 | 580,300 |
| Annual Sales | 0 | 42,879,000,000 | 8,352,100,000 | 3,897,500,000 | 5,439,500,000 |
| Annual Net Income | -25,500,000 | 6,335,000,000 | 2,322,600,000 | 887,870,000 | 4,174,600,000 |
| Last Quarter Sales | 0 | 11,122,000,000 | 2,505,100,000 | 1,105,240,000 | 1,553,100,000 |
| Last Quarter Net Income | -8,690,000 | 1,616,000,000 | 704,400,000 | 274,610,000 | 291,100,000 |
| 60-Month Beta | 0.95 | 0.90 | 1.68 | 1.67 | 0.97 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 11/12/25 | 5.79 on 10/22/25 | 2.40 on 10/21/25 | 3.40 on 11/03/25 | 0.67 on 10/30/25 |
| Latest Earnings Date | 03/24/26 | 01/29/26 | 01/22/26 | 02/02/26 | 02/10/26 |
| Most Recent Dividend | N/A | 0.430 on 12/15/25 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 12/15/25 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.62 | 77.97 | 55.66 | 32.65 |